Browse the full management transaction log of Albemarle CORP, a listed issuer based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Chemicals & Materials sector, Albemarle CORP has logged 86 public disclosures. Market capitalisation: €21.3bn. The latest transaction was disclosed on 4 March 2026 — Attribution. Among the most active insiders: NARWOLD KAREN G. Every trade is accessible without an account.
25 of 86 declarations
Albemarle Corp. (NYSE: ALB) is a U.S.-based specialty chemicals company listed on the New York Stock Exchange in the United States, with headquarters in Charlotte, North Carolina. The company’s roots date back to 1887, while Albemarle Corporation became a publicly traded entity in 1994. Over time, the business has evolved from its historical industrial and paper heritage into a more focused specialty-chemicals platform centered on lithium, bromine and catalysts. ([albemarle.com](https://www.albemarle.com/sites/default/files/2025-04/Albemarle-Corporate-FactSheet-2025-27-03_2.pdf)) Today, Albemarle positions itself as one of the world’s largest lithium suppliers and an industry leader in bromine solutions. Its main operating pillars are lithium solutions, bromine solutions and catalysts. The lithium franchise includes lithium hydroxide, lithium carbonate, lithium metal and specialty organometallics and salts used in batteries for electric vehicles, energy storage and broader industrial applications. The bromine portfolio spans flame retardants, industrial water treatment, fire safety, environmental remediation and drilling-fluid applications, while its catalyst business serves refining and petrochemical customers. This mix gives the company exposure to both energy-transition demand and more traditional industrial end markets. ([albemarle.com](https://www.albemarle.com/sites/default/files/2025-04/Albemarle-Corporate-FactSheet-2025-27-03_2.pdf)) Geographically, Albemarle has a broad global footprint and serves customers in approximately 70 countries. The company highlights a differentiated asset base that includes the only operating lithium mine in the United States, alongside brine assets in Chile, hard-rock and JV assets in Australia, and conversion and R&D facilities across North America, South America, Europe and Asia. That integration from mine and brine to finished chemicals is a key competitive advantage, supporting supply reliability and product quality. ([albemarle.com](https://www.albemarle.com/sites/default/files/2025-04/Albemarle-Corporate-FactSheet-2025-27-03_2.pdf)) From a competitive standpoint, Albemarle benefits from scale, resource quality, technical know-how and long-standing customer relationships. At the same time, the company remains highly sensitive to lithium price cycles, which have weighed on earnings and capital allocation in recent periods. Recent corporate updates show a more disciplined operating posture: during 2025 the company emphasized cost and productivity actions, and in February 2026 it announced plans to idle the remaining operating train at its Kemerton lithium hydroxide processing plant in Western Australia to preserve financial flexibility. Albemarle’s full-year 2025 results also pointed to positive operating cash flow and meaningful free cash flow generation, with 2026 capex guided to remain roughly flat versus 2025. For investors, the name therefore combines strategic exposure to electrification with a still-cyclical earnings profile. ([investors.albemarle.com](https://investors.albemarle.com/news-and-events/news/news-details/2026/Albemarle-Reports-Fourth-Quarter-and-Full-Year-2025-Results/default.aspx?utm_source=openai))